Hims & Hers Health (HIMS) Competitors $29.48 +1.18 (+4.15%) Closing price 03:59 PM EasternExtended Trading$28.55 -0.93 (-3.17%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, FMS, GH, OPCH, RDNT, BTSG, SHC, PRVA, PIII, and WGSShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care (FMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), P3 Health Partners (PIII), and GeneDx (WGS). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Natera Fresenius Medical Care Guardant Health Option Care Health RadNet BrightSpring Health Services Sotera Health Privia Health Group P3 Health Partners GeneDx Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation. Does the media refer more to NTRA or HIMS? In the previous week, Hims & Hers Health had 3 more articles in the media than Natera. MarketBeat recorded 26 mentions for Hims & Hers Health and 23 mentions for Natera. Natera's average media sentiment score of 1.30 beat Hims & Hers Health's score of 0.77 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 16 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 14 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate NTRA or HIMS? Natera currently has a consensus target price of $175.76, indicating a potential upside of 15.83%. Hims & Hers Health has a consensus target price of $38.25, indicating a potential upside of 29.73%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Hims & Hers Health is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.21 Which has more risk and volatility, NTRA or HIMS? Natera has a beta of 1.8, suggesting that its stock price is 80% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Is NTRA or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to Natera's net margin of -14.01%. Hims & Hers Health's return on equity of 10.97% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Natera-14.01% -26.23% -14.27% Hims & Hers Health 8.19%10.97%8.29% Do insiders and institutionals hold more shares of NTRA or HIMS? 99.9% of Natera shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 7.6% of Natera shares are owned by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, NTRA or HIMS? Hims & Hers Health has lower revenue, but higher earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B12.09-$434.80M-$1.53-99.18Hims & Hers Health$1.48B4.44-$23.55M$0.5454.60 Does the MarketBeat Community favor NTRA or HIMS? Natera received 448 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.96% of users gave Natera an outperform vote while only 36.44% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformNateraOutperform Votes49168.96% Underperform Votes22131.04% Hims & Hers HealthOutperform Votes4336.44% Underperform Votes7563.56% SummaryNatera and Hims & Hers Health tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$6.55B$1.03B$5.33B$18.51BDividend YieldN/AN/A5.11%4.24%P/E Ratio67.0117.0421.7331.15Price / Sales4.441.09379.1425.69Price / CashN/A36.0138.1517.53Price / Book18.318.196.464.29Net Income-$23.55M-$52.07M$3.20B$1.02B7 Day Performance13.31%9.20%6.54%6.59%1 Month Performance-10.93%12.75%-8.55%-6.88%1 Year Performance123.03%-10.69%10.33%1.23% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health3.5701 of 5 stars$29.49+4.2%$38.25+29.7%+102.1%$6.55B$1.48B67.01650NTRANatera3.0879 of 5 stars$148.76+0.5%$175.76+18.2%+57.1%$20.11B$1.70B-84.523,020Positive NewsGap DownFMSFresenius Medical Care3.0906 of 5 stars$24.62+2.7%$25.30+2.8%+34.0%$14.45B$19.34B20.35123,200Positive NewsGap DownGHGuardant Health3.6829 of 5 stars$45.22+3.5%$49.00+8.4%+147.3%$5.58B$739.02M-12.701,790OPCHOption Care Health3.1232 of 5 stars$31.38-0.5%$33.00+5.2%+4.7%$5.15B$5.00B26.375,600Short Interest ↑Positive NewsRDNTRadNet3.828 of 5 stars$52.86-1.0%$69.75+32.0%+10.0%$3.91B$1.83B-755.038,970News CoveragePositive NewsBTSGBrightSpring Health Services2.906 of 5 stars$17.21+0.7%$21.67+25.9%+70.1%$3.01B$11.27B-66.1935,000News CoverageGap DownSHCSotera Health2.4029 of 5 stars$10.51flat$15.20+44.6%-5.9%$2.98B$1.10B42.043,000Gap DownPRVAPrivia Health Group3.8867 of 5 stars$24.02-0.3%$26.87+11.9%+29.7%$2.91B$1.74B240.22810Analyst ForecastPIIIP3 Health Partners1.7858 of 5 stars$7.94+4.8%$0.25-96.9%-69.2%$2.85B$1.50B-9.46500News CoverageGap DownWGSGeneDx1.8148 of 5 stars$98.92+2.4%$72.33-26.9%+950.3%$2.78B$305.45M-50.471,200Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies NTRA Competitors FMS Competitors GH Competitors OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors PRVA Competitors PIII Competitors WGS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIMS Stock Free HIMS Stock Alerts